Urothelial Cancer Clinical Trials in Washington D.C., District of Columbia

4 studies are recruiting for urothelial cancer in Washington D.C., District of Columbia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

    This study, the first clinical trial of AVZO-1418, aims to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, maximum tolerated dose, and antitumor activity of AVZO-1418 when administered intravenously as a monotherapy and potentially in combination therapy to patients with loc…

    Stage
    Phase 1
    Ages
    18 to 75
    Site
    Avenzo Therapeutics Recruiting Site, Washington D.C., District of Columbia
    Locations
    19 in total
    Run by
    Avenzo Therapeutics, Inc.

    See if you can join NCT07038343 on ClinicalTrials.gov

  2. A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

    This is a study to evaluate the safety and preliminary anti-tumor activity of STRO-004 in adults with metastatic cancer. This study includes 3 parts: * Part 1A is a dose escalation study of STRO-004 monotherapy in selected tumor types known to commonly express Tissue Factor (TF). * Part 1B is a coh…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Georgetown University Medical Center, Washington D.C., District of Columbia
    Locations
    9 in total
    Run by
    Sutro Biopharma, Inc.

    See if you can join NCT07227168 on ClinicalTrials.gov

  3. Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

    This study is being done to learn more about a new medicine called PF-08634404. It is for adults with a type of bladder cancer called locally advanced or metastatic urothelial cancer (LA/mUC), meaning the cancer has spread to nearby tissues or other parts of the body. The purpose of the study is to…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Sibley Memorial Hospital Pharmacy Department, Washington D.C., District of Columbia
    Locations
    153 in total
    Run by
    Pfizer

    See if you can join NCT07421700 on ClinicalTrials.gov

  4. Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

    A Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer with Disease Progression on or After Immunotherapy

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Sibley Memorial Hospital, Washington D.C., District of Columbia
    Locations
    163 in total
    Run by
    Bristol-Myers Squibb

    See if you can join NCT07106762 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.